Asia Pacific Topical Drugs Contract Manufacturing Market Size & Outlook
Related Markets
Asia Pacific topical drugs contract manufacturing market highlights
- The Asia Pacific topical drugs contract manufacturing market generated a revenue of USD 11,183.2 million in 2024.
- The market is expected to grow at a CAGR of 11.7% from 2025 to 2030.
- In terms of segment, semi-solid formulations was the largest revenue generating product type in 2024.
- Semi-solid Formulations is the most lucrative product type segment registering the fastest growth during the forecast period.
- Country-wise, India is expected to register the highest CAGR from 2025 to 2030.
Asia Pacific data book summary
| Market revenue in 2024 | USD 11,183.2 million |
| Market revenue in 2030 | USD 21,582.5 million |
| Growth rate | 11.7% (CAGR from 2025 to 2030) |
| Largest segment | Semi-solid formulations |
| Fastest growing segment | Semi-solid Formulations |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Semi-solid Formulations, Liquid Formulations, Solid Formulations, Transdermal Products |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 38.2% of the global topical drugs contract manufacturing market in 2024.
- Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 21,582.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Topical Drugs Contract Manufacturing Market Scope
Topical Drugs Contract Manufacturing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Abbvie Contract Manufacturing | View profile | 10001+ | North Chicago, Illinois, United States, North America | https://abbviecontractmfg.com |
| Cambrex Corporation | View profile | - | - | - |
| NextPharma Technologies | View profile | - | - | - |
| MedPharm | View profile | 51-100 | Guildford, Surrey, United Kingdom, Europe | https://www.medpharm.com |
| Catalent Pharma Solutions | View profile | 5001-10000 | Somerset, New Jersey, United States, North America | http://www.catalent.com |
| Kindeva Drug Delivery | View profile | 501-1000 | Saint Paul, Minnesota, United States, North America | https://www.kindevadd.com/ |
| DPT Laboratories | View profile | 1001-5000 | San Antonio, Texas, United States, North America | https://www.dptlabs.com |
| Bora Pharmaceuticals | View profile | 501-1000 | Taipei, T'ai-pei, Taiwan, Asia | http://www.bora-corp.com/ |
| SGS AG | View profile | 103193 | 1 Place des Alpes, P.O. Box 2152, Geneva, Switzerland, CH-1211 | https://www.sgs.com |
| The Lubrizol Corp | View profile | 5001-10000 | Wickliffe, Ohio, United States, North America | http://www.lubrizol.com/ |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Lonza Group Ltd | View profile | 18000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | https://www.lonza.com |
Asia Pacific topical drugs contract manufacturing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to topical drugs contract manufacturing market will help companies and investors design strategic landscapes.
Semi-solid formulations was the largest segment with a revenue share of 75.4% in 2024. Horizon Databook has segmented the Asia Pacific topical drugs contract manufacturing market based on semi-solid formulations, liquid formulations, solid formulations, transdermal products covering the revenue growth of each sub-segment from 2018 to 2030.
The region’s growth is driven by various factors, including increasing pharmaceutical spending, growing need for novel innovation, rising emphasis on advanced drug delivery technologies, and increasing prevalence of diseases. Besides, low manufacturing costs attract numerous pharmaceutical companies from developed nations to outsource their manufacturing to the Asia Pacific, contributing to market growth.
Moreover, expanding R&D activities and the presence of both local and established contract manufacturers enhancing their global capabilities are expected to drive the market. Besides, the regional market offers a range of advantages in producing semi-solid, liquid, and transdermal formulations, making it attractive for global pharmaceutical companies searching for scalable manufacturing solutions.
Furthermore, rising healthcare spending and investments in GMP-compliant facilities are some of the factors driving the market. Such factors are expected to boost the market over the estimated period.
Reasons to subscribe to Asia Pacific topical drugs contract manufacturing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific topical drugs contract manufacturing market databook
-
Our clientele includes a mix of topical drugs contract manufacturing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific topical drugs contract manufacturing market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific topical drugs contract manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific topical drugs contract manufacturing market size, by country, 2018-2030 (US$M)
Asia Pacific Topical Drugs Contract Manufacturing Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
